Stocks · Health care · Pharmaceutical Preparations

UroGen Pharma Ltd.

URGN Clue Score39

Israel Fiscal year ends December CIK 0001668243 Results filed 4 Nov 2026

Add to watchlist

What the insiders did Scheduled selling only

By person

8 insiders · 1 transaction

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Chris Degnan

Chief Financial Officer

—

$80.79K (1) scheduled

−$80.79K

4,561

0.0093%

$167.34K

—

Mark Schoenberg

Chief Medical Officer

—

—

—

59,882

0.1225%

$2.20M

−58.7%

Jason Drew Smith

General Counsel

—

—

—

53,141

0.1087%

$1.95M

+110.7%

James A. Robinson Jr.

Director

—

—

—

8,000

0.0164%

$293.52K

—

Leana Wen

Director

—

—

—

2,000

0.0041%

$73.38K

—

Daniel George Wildman

Director

—

—

—

2,000

0.0041%

$73.38K

—

Stuart Holden

Director

—

—

—

2,000

0.0041%

$73.38K

—

Cynthia M Butitta

Director

—

—

—

2,000

0.0041%

$73.38K

—